Literature DB >> 2204499

Effect of protein kinase C activation on sarcoplasmic reticulum function and apparent myofibrillar Ca2+ sensitivity in intact and skinned muscles from normal and diseased human myocardium.

J K Gwathmey1, R J Hajjar.   

Abstract

Protein kinase C regulates the activity of a diverse group of cellular proteins including membrane ion channel proteins. Although protein kinase C and its substrate protein have been identified in both membrane and cytosolic fractions in the heart, the physiological role of this kinase in the regulation of cardiac function remains unknown. We examined the physiological role of protein kinase C by stimulating its activity with 12-deoxyphorbol 13 isobutyrate 20 acetate (DPBA) in human trabeculae carneae. This resulted in decreased peak isometric twitch force and peak intracellular sarcoplasmic reticulum calcium release as detected with aequorin. Furthermore, in the presence of DPBA, steady-state force-[Ca2+] relations were shifted to higher intracellular calcium concentrations, and the Hill coefficient was reduced, indicating a decrease in responsiveness of the myofilaments to calcium and a change in cooperativity among thin filament proteins, respectively. Thus, DPBA affects not only intracellular calcium concentration, but myofilament calcium interactions as well. The effect of DPBA on Ca2+ activation probably reflects phosphorylation of thin-filament regulatory proteins by protein kinase C.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2204499     DOI: 10.1161/01.res.67.3.744

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  20 in total

1.  Protein kinase C phosphorylation of cardiac troponin T decreases Ca(2+)-dependent actomyosin MgATPase activity and troponin T binding to tropomyosin-F-actin complex.

Authors:  T A Noland; J F Kuo
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

2.  Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies: role of altered beta-adrenergically mediated protein phosphorylation.

Authors:  M R Wolff; S H Buck; S W Stoker; M L Greaser; R M Mentzer
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

3.  Molecular and cellular actions of platelet-activating factor in rat heart cells.

Authors:  C V Massey; T A Kohout; S T Gaa; W J Lederer; T B Rogers
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

Review 4.  Cardiac alpha(1)-adrenoceptors that regulate contractile function: subtypes and subcellular signal transduction mechanisms.

Authors:  M Endoh
Journal:  Neurochem Res       Date:  1996-02       Impact factor: 3.996

5.  Ca(2+)-sensitizing effect is involved in the positive inotropic effect of troglitazone.

Authors:  Y Furuse; K Ogino; M Shimoyama; N Sasaki; I Hisatome
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

Review 6.  In situ study of myofibrils, mitochondria and bound creatine kinases in experimental cardiomyopathies.

Authors:  V Veksler; R Ventura-Clapier
Journal:  Mol Cell Biochem       Date:  1994 Apr-May       Impact factor: 3.396

7.  Different patterns of protein kinase C redistribution mediated by alpha 1-adrenoceptor stimulation and phorbol ester in rat isolated left ventricular papillary muscle.

Authors:  H Otani; M Hara; X T Zeng; K Omori; C Inagaki
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

8.  The effects of FMRFamide, 5-hydroxytryptamine and phorbol esters on the heart of the mussel Geukensia demissa.

Authors:  N A Bayakly; L E Deaton
Journal:  J Comp Physiol B       Date:  1992       Impact factor: 2.200

9.  Protein kinase C enhances myosin light-chain kinase effects on force development and ATPase activity in rat single skinned cardiac cells.

Authors:  O Clement; M Puceat; M P Walsh; G Vassort
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

Review 10.  Calcium-sensitizing inotropic agents in the treatment of heart failure: a critical view.

Authors:  R J Hajjar; J K Gwathmey
Journal:  Cardiovasc Drugs Ther       Date:  1991-12       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.